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Abstract
In the presented work, raw materials (fruits and leaves) and in vitro biomass of a highly productive Schisandra chinensis Sadova No. 1
cultivar (SchS)were evaluated for the production of therapeutically useful schisandra lignans (SL). In vitro cultures of SchSwere initiated,
followed by extensive optimization studies focused on maximizing secondary metabolite production, with the aim of establishing a
sustainable source of SL. Different cultivation systems (agar, agitated, bioreactor), experiment times (10, 20, 30, 40, 50 and 60 days) and
plant growth regulators (6-benzyladenine—BA and 1-naphthaleneacetic acid—NAA, from 0 to 3 mg/l) in Murashige-Skoog (MS)
mediumwere tested.Moreover, an elicitation procedure was applied to bioreactor-grownmicroshoots in order to increase SL production.
Validated HPLC-DAD protocol enabled to detect fourteen SL in the extracts from in vitro and in vivo materials. Themain compounds in
the in vitro cultures were as follows: schisandrin (max. 176.3 mg/100 g DW), angeloylgomisin Q (max. 85.1 mg/100 g DW), gomisin A
(max. 71.4 mg/100 g DW) and angeloylgomisin H (max. 67.0 mg/100 g DW). The highest total SL content (490.3 mg/100 g DW) was
obtained in extracts from the biomass of agar cultures cultivated for 30 days on theMSmedium variant containing 3mg/l BA and 1mg/l
NAA.This amountwas 1.32 times lower than in fruit extracts (646.0mg/100 gDW) and2.04 times higher than in leaf extracts (240.7mg/
100 g DW). The study demonstrated that SchS is a rich source of SL, thus proving its value for medical, cosmetic and food industry.
Keywords Chinese magnolia vine cultivar . Schisandra lignans . In vitro cultures . Agar culture . Agitated culture . Bioreactor
culture . Elicitation
Introduction
Schisandra chinensis (Turcz.) Baill.—the Chinese magnolia
vine, or schisandra (Sch)—is a pharmacopoeial species of
documented therapeutic importance (Szopa et al. 2017a).
The raw material is the schisandra fruit—Schisandrae
chinensis fructus; it has monographs not only in the pharma-
copoeias of Asian countries (Central Pharmaceutical Affairs
Council 2002; Chinese Pharmacopoeia Commission 2005;
Committee of the Japanese Pharmacopoeia 2006), but also
in the European (European Directorate for the Quality of
Medicines 2017) and American Pharmacopoeias (Upton
et al. 2011), as well as in the International Pharmacopoeia
published by the WHO (World Health Organization 2007).
Sch fruits exhibit many valuable biological activities, e.g. he-
patoprotective, adaptogenic and ergogenic, antitumour,
immunostimulant, anti-inflammatory, anti-ulcer, antioxidant
and detoxifying, and also antiviral and antimicrobial.
Extracts from the fruit have a positive effect on the functioning
of the cardiovascular and respiratory systems, and show anti-
osteoporotic and anti-obesity activities (Hancke et al. 1999;
Szopa et al. 2017a). They are also used in cosmetic industry as
antioxidant, immunostimulant and antiphlogistic agent (Szopa
et al. 2016a). The valuable pharmacological and
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cosmetological properties are determined by the unique chem-
ical composition of Sch. The main group of secondary metab-
olites which are unique to this species and responsible for its
biological activities is dibenzocyclooctadiene lignans, also
called ‘schisandra lignans’ (SL) (Opletal et al. 2004).
Hitherto, we have analysed SL in fruit and leaf extracts
from Sch (Szopa and Ekiert 2011). Moreover, different types
of Sch in vitro cultures (agar, agitated, stationary liquid and
bioreactor-grown), were analysed which can be considered as
a potential alternative source of aforementioned compounds
(Szopa et al. 2016b, 2017b, 2018).
In the present study, a cultivated variety of S. chinensis,
namely S. chinensis cv. Sadova No. 1 (further referred to as
‘SchS’), was investigated for SL production. SchS is a
Ukrainian cultivar of Sch, which was selected by Ivan
Shaitan in the M. M. Grishko National Botanical Garden in
Kiev. The SchS cultivar entered the State Register of Plants in
Ukraine in 1998 (Shaitan 2005). It was created from selected
seeds of wild Sch specimens growing in Primorsk. The
resulting plants are characterized by vigorously growing
shoots and large clusters of fruits. The fruits have a sour taste,
juicy flesh and bright red juice. As compared to original spe-
cies, the Sadova cultivar is more productive and resistant to
harsh climate events (Shaitan 2005). However, according to
the data revealed by literature review, little is known about the
chemical composition of SchS. The fruits of SchS were
shown to contain ascorbic acid, sugars and organic
acids (Shaitan 2005), but there are no data on the levels
of the main group of schisandra secondary metabolites,
i.e. SL. Given the above, aims of the current study were
formulated: firstly, to evaluate SL content in leaves and
fruits of SchS, following to establish in vitro cultures of
SchS for sustainable production of SL.
The biotechnological experiments (upstream procedures)
included culture initiation and optimization of the growth con-
ditions in terms of selecting the culture type (agar, agitated,
bioreactor—Plantform temporary immersion system), culture
duration (10, 20, 30 40, 50, 60 days) and plant growth regu-
lators (PGRs) used (BA and NAA; in the concentration range
from 0 to 3 mg/l) in Murashige and Skoog medium (MS,
(Murashige and Skoog 1962)). Moreover, in order to increase
the production of SL, the elicitation strategy with yeast extract
was performed on microshoots cultivated in a Plantform
bioreactor.
The high-performance liquid chromatography with diode
array detection (HPLC-DAD) was selected for all phytochem-
ical analyses (downstream procedures) which included vali-
dation of the method as far as determination of SL was
concerned.
To the best of our knowledge, this is the first report describ-
ing a phytochemical analysis of SL in fruit and leaf extracts of
SchS. Moreover, innovative biotechnological approach was
employed in order to establish sustainable production of SL.
Materials and methods
Origin of plant material
The plant material for the study was a specimen of the parent
plant—Schisandra chinensis Sadova No. 1 (SchS) growing in
a commercial nursery, Clematis—Źródło Dobrych Pnączy
Spółka z o.o.—is a limited partnership company with its reg-
istered office in Pruszków (ul. Duchnicka 27, 05-800
Pruszków, Poland) (http://www.clematis.com.pl/). The plant
was taxonomically verified by the scientific staff of the
Clematis arboretum. The plant material consisted of the
leaves and fruits of SchS harvested in August 2015. After
harvesting, the leaves and fruits were preserved by
lyophilization (Labconco lyophilizer).
In vitro cultures
Initiation of in vitro cultures
The material for establishment of in vitro cultures consisted of
apical buds (obtained in spring 2015) from the SchS specimen
described above (section ‘Origin of plant material’). The plant
material was treated with 70% ethanol (30 s); then, it was
disinfected with a 0.1% HgCl2 solution for 10 min, washed
three times with sterile water and inoculated onto the standard
MS (Murashige and Skoog 1962) medium with 0.8% (w/v)
agar (plant agar, Duchefa), 3% (w/v) sucrose, 1 mg/l BA (6-
benzyladenine) and 0.5 mg/l NAA (1-naphthaleneacetic acid).
After approx. 8-weeks, viable, green microshoot cultures were
established. The in vitro cultures were maintained at 25 ± 2 °C
under continuous artificial illumination at 2.75 W/m2 (LF-
40 W lamp, daylight, Piła) and subcultured at 4-week
intervals.
Experimental in vitro cultures
Agar microshoot cultures The study involved cultivating
microshoots of SchS. Two types of cultures were tested: sta-
tionary (agar) and agitated (liquid). In the stationary system,
shoot cultures (Fig. 1; Online resource) were maintained on
different variants of the standard MS (Murashige and Skoog
1962) mediumwith 0.8% (w/v) agar (plant agar, Duchefa) and
3% (w/v) sucrose. The testedmedia differed with respect to the
concentrations of plant growth regulators (PGRs)—BA and
NAA (mg/l): 0.1 and 2 (variant B), 0.5 and 2 (variant C), 2 and
0.5 (variant D), 2 and 1 (variant E), 2 and 2 (variant F) and 3
and 1 (variant G). The medium combination without PGRs
(control) was designated as variant A. The inoculumwas 0.5 g
of shoots, taken from the previously established microshoot
culture (section ‘Initiation of in vitro cultures’) on the 30th day
of the growth cycle. The experimental cultures were main-
tained in Magenta™ vessels (Sigma, product No. V8630)
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containing 30 ml of MS medium. Microshoots were grown
under continuous white light (2.75 W/m2), at 25 ± 2 °C, over
60-day growth periods. The biomass was collected at 10-day
intervals, after 10, 20, 30, 40, 50 and 60 days of the
experiment.
Agitated microshoot cultures Agitated microshoot cultures
(Fig. 2) were cultivated in 300 ml Erlenmeyer flasks con-
taining 100 ml of MS medium, on a rotary shaker (Altel) at
140 rpm. The inoculum was composed of 1.5 g microshoot
sections (prepared as described in ‘Agar microshoot cul-
tures’). The agitated cultures were maintained on two vari-
ants (F and G, as described in ‘Agar microshoot cultures’) of
the standard liquid MS (Murashige and Skoog 1962) me-
dium with 3% (w/v) sucrose and containing respectively:
2 mg/l BA and 2 mg/l NAA—variant F, and 3 mg/l BA
and 1 mg/l NAA—variant G (the choice of growth reg-
ulator compositions was made due to the fact that these
variants had the best growth and production results for
agar cultures).
The nutrient media and biomass samples from the agitated
cultures were collected at 10-day intervals on 10, 20, 30, 40,
50 and 60 day of the culture. SchS microshoots were grown
under continuous white light (2.75 W/m2), at of 25 ± 2 °C.
Bioreactor cultures SchS shoots were grown for 30 days in the
Plantform temporary immersion system (Plant Form, Sweden)
(Fig. 3), following the protocol described previously (Szopa
et al. 2017b). The bioreactor was inoculated at 15/500 (g/ml)
microshoots to medium ratio (variant G of MS medium of
3 mg/l BA and 1 mg/l NAA) (the best growth and production
medium for SchS microshoots). The immersion cycle was set
to 5 min every 1.5 h, at 1.0 vvm aeration rate.
For the Plantform bioreactor experiments, an elicitation
with 1000 mg/l of yeast extract (YE) (plant cell culture tested,
Sigma-Aldrich), added on day 20 of the 30-day growth period,
was applied, according to elicitation protocol described previ-
ously (Szopa et al. 2018). The YE for the elicitor treatments
was steam-sterilized (120 °C, 20 min, 1 bar) prior to use. For
elicitation, one of the side hose nipples of the Plantform
Culture growth 
period 
MS medium variants 
A B C D 
10 days 
20 days 
30 days 
40 days 
50 days 
60 days 
Fig. 1 Morphological appearance of S. chinensis cv. Sadova microshoots
grown for 10–60 days on different MS (Murashige and Skoog) agar
media variants: A—control (without PGRs), B—0.1 mg/l BA and
2 mg/l NAA, C—0.5 mg/l BA and 2 mg/l NAA, D—2 mg/l BA and
0.5 mg/l NAA, E—2mg/l BA and 1mg/l NAA, F—2mg/l BA and 2mg/
l NAA, G—3 mg/l BA and 1 mg/l NAA
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bioreactor was used as an inlet port. Samples of the
microshoots and the media were collected on day 30 of the
experiment.
Chromatographic assays
Extraction
For the preparation of methanolic extracts, 0.3 g por-
tions of lyophilized (Labconco lyophilizer) and pulver-
ized matrices (intact plant material and biomass from
in vitro cultures) were weighed out. The material was
subjected to extraction with 5-ml methanol (STANLAB,
Poland) by sonication in an ultrasonic bath (POLSONIC
2, Poland) for 30 min. Freeze-dried samples of the ex-
perimental media from agitated and bioreactor cultures
were also subjected to extraction in this manner. The
obtained extracts were filtered through sterilizing sy-
ringe filters (0.22 μm, Millex®GP, Millipore) prior to
HPLC analysis.
Phytochemical analysis
Analysis of dibenzocyclooctadiene lignans (SL) was per-
formed by HPLC-DAD according to the method originally
developed by Zhang et al. (Zhang et al. 2009) for Sch fruits,
and subsequently adapted for Sch in vitro cultures in the
course of our previous work (Szopa et al. 2016b). The
Hitachi LaChrom Elite® HPLC system was used equipped
with a DAD detector L-2455, column oven L-2350 and
autosampler L-2200r. Separation was performed using a
Kinetex™ C-18 analytical column (150 × 4.6 mm, 2.6-μm
particle size; Phenomenex, USA) at 30 °C. The mobile phase
consisted of acetonitrile (A) and water (B), with a flow-rate of
0.8 ml/min. The gradient program was as follows: 0–4 min,
40–45; 4–12 min, 45–50; 12–16 min, 50–68; 16–20 min, 68–
75; 20–25 min, 75–95 (% B), with a hold time of 15 min;
injection volume was 5 μl. Detection wavelength was set at
225 nm. Identification and quantification were made by com-
parison of UV spectra and retention times with nine standards:
gomisin A, deoxyschisandrin, schisandrin and γ-schisandrin
(ChromaDex®, USA), gomisin G and schisantherin A
Culture 
growth 
period
MS medium variants
E F G
10 days
20 days
30 days
40 days
50 days
60 days
Fig. 1 (continued)
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(PhytoLab GmbH & Co. KG, Germany), schisandrin C,
schisantherin B and schisanthenol (ChemFaces Biochemical
Co. Ltd., China). Additionally, based on our previous studies
(Szopa et al. 2016b), quantification of five tentatively identi-
fied compounds, schisandrin B, benzoylgomisin P, angeloyl-/
tigloylgomisin H, angeloyl-/tigloylgomisin Q, schisantherin D
(or one of its stereoisomers—benzoylgomisin O or
benzoylisogomisin O) (based on HPLC-DAD-ESI/MS analy-
ses), was performed using the calibration curve for
schisandrin, as the main component of the group of SL. The
representative HPLC-UV chromatogram (λ = 225 nm) of a
methanol extract of SchS biomass cultivated in vitro was pre-
sented in Fig. 4.
Validation
Validation of the HPLC-DAD method was performed by de-
termination of accuracy, precision, linearity, limit of detection
and limit of quantification (European Medicines Agency
2005).
Accuracy
Accuracy was determined based on sample analysis of known
concentrations and comparing the results obtained by a vali-
dated method with true values, followed by calculation of the
recovery percentage. Determinations were performed at three
concentration levels: 80, 100 and 120%, for each of them three
repetitions were done.
Culture growth period 
MS medium variants 
GF
10 days 
20 days 
30 days 
40 days 
50 days 
60 days 
Fig. 2 Morphological appearance
of S. chinensis cv. Sadova agitated
microshoots grown for 10–
60 days in different liquid media
variants: F—2mg/l BA and 2mg/
l NAA, G—3 mg/l BA and 1 mg/l
NAA
Fig. 3 S. chinensis cv. Sadova microshoots grown for 30 days in
temporary immersion system (Plantform bioreactor) on MS medium
variant G (3 mg/l BA and 1 mg/l NAA)
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Precision
Precision of the method was determined at three levels of
substance concentrations in reference solutions: 50, 100 and
150%. For each level of concentration, three repetitions were
done.
Linearity
Linearity was determined by comparing the relationship be-
tween peak area and a concentration of the tested substances
(mg/ml). Two series of assays in the following concentration
range were made for deoxyschisandrin: from 0.0039 to
1.0000 mg/ml, for γ-schisandrin: from 0.0013 to 1.0000 mg/
ml and in the following concentration ranges: 0.0200 to
0.2000 mg/ml for other SL.
Limit of detection and limit of quantification
The limit of detection (LOD) and limit of quantification
(LOQ) were determined from the linearity in the following
concentration ranges: from 0.0039 to 0.0312 mg/ml for
deoxyschisandrin, from 0.0013 to 0.0050 mg/ml for
γ-schisandrin and from 0.0200 to 0.1000 mg/ml for other
SL, using the following formulas: LOD = 3.3 × Sy/a, LOQ =
10 × Sy/a, where Sy is the estimation error and a is the slope.
Statistical analysis
The data presented, were organized with independent
samples (three replications). Analyses and measurements
of each sample were performed in triplicate and average
values were used for statistical evaluation. The signifi-
cant differences in the individual and total contents of
estimated SL contents were compared with the one-way
analysis of variance (one-way ANOVA). For comparison
and contrast between different amounts, post hoc Tukey
HSD (honestly significant difference) test was used.
Outcomes demonstrating p < 0.05 were considered statis-
tically significant. Data analysis was performed using
STATISTICA 13 PL (StatSoft) software.
The experiments have been repeated thrice. The results
were presented as mean ± standard deviation (SD). The
STATISTICA version 13 PL software package (StatSoft)
was used for the analysis.
Results
Validation setup
The validation results presented in Table 1 indicate that the
proposed HPLC-DAD method is characterized by high sensi-
tivity; LOD for deoxyschisandrin is 0.0089 mg/ml,
0.0050 mg/ml for schisandrin, 0.0120 mg/ml for gomisin A,
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Fig. 4 The representative HPLC-UV chromatogram (λ = 225 nm) of a
methanol extract of S. chinensis cv. Sadova biomass cultivated in vitro.
SL: 1—schisandrin, 2—gomisin, 3—angeloyl-/tigloylgomisin, 4—
angeloyl-/tigloylgomisin Q, 5—gomisin G, 6—schisantherin A, 7—
schisantherin B, 8—schisanthenol, 9—deoxyschisandrin, 10—
schisandrin B, 11—γ-schisandrin, 12—benzoylgomisin P, 13—
schisandrin, 14—schisantherin D
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0.0048 mg/ml for γ-schisandrin, 0.0044 mg/ml for
schisandrin C, 0.0095 mg/ml for schisanthenol, 0.0151 mg/
ml for schisantherin B, 0.0103 mg/ml for gomisin G and
0.0093 mg/ml for schisantherin A. LOQ was estimated at
0.0269, 0.0151, 0.0372, 0.0145, 0.0133, 0.0288, 0.0457,
0.0312, 0.0185 and 0.0282 mg/ml, respectively. Percentage
recovery of the studied compounds presented as mean values
for three concentration levels is high and ranges from 95.77 to
103.90%. Satisfactory precision determined for three concen-
tration levels is confirmed by the values of variability coeffi-
cients RSD which are in the range from 0.21 to 2.96%.
Linearity of the tested substances was preserved in a wide
range: from 0.0039 to 1.0000 mg/ml for deoxyschisandrin,
from 0.0013 to 1.0000 mg/ml for γ-schisandrin and in the
following concentration ranges: 0.0200 to 0.2000 mg/ml for
other substances.
Phytochemical analysis of plant material
Fruits
The SchS fruit extracts were found to contain all of the 14
lignans analysed. The concentrations of the individual com-
pounds varied within a broad range from 2.6 to 166.8 mg/
100 g DW (dry weight). In quantitative terms, the dominant
metabolites were as follows: schisandrin (166.8 mg/100 g
DW), γ-schisandrin (96.2 mg/100 g DW), gomisin A
(72.4 mg/100 g DW), angeloylgomisin H (71.6 mg/100 g
DW) and schisantherin B (56.8 mg/100 g DW). The total SL
content in fruit extracts was 646.0 mg/100 g DW (Table 2).
Leaves
The SchS leaf extracts were found to contain all of the 14
lignans analysed. The concentrations of the individual com-
pounds varied within a broad range from 1.4 to 55.1 mg/100 g
DW. The main metabolites were as follows: schisandrin
(55.1 mg/100 g DW), angeloylgomisin H (31.4 mg/100 g
DW), schisantherin D (31.3 mg/100 g DW) and γ-schisandrin
(24.5 mg/100 g DW). The total SL content in leaf extracts was
240.7 mg/100 g DW (Table 2).
Phytochemical analysis of in vitro cultures
Agar microshoot cultures
Microshoots growing on the six agar variants of MS medium,
containing different concentrations of PGRs, especially on
variants F and G, were characterized by a large number of
microshoots and a dark green color of the leaves. The shoots
growing on variant A of MS medium (control without PGRs)
had a smaller number of microshoots and a pale green colour
(Fig. 1). The resulting values of the growth index (Gi) ranged
from 2.3 to 8.7, depending on the medium variant and culture
duration. The highest values were obtained for microshoots
cultivated for 60 days on variant G of the medium (Table 3).
The experiments on the accumulation of SL in SchS agar
cultures were carried out on six variants of MS medium with
different concentrations of PGRs: BA and NAA (variants B–
G), and a medium containing no PGRs as control conditions
(variant A). The PGRs applied in the tested variants of MS
medium as well as the duration of the culture cycle signifi-
cantly influenced the amounts of all the 14 lignans analysed in
the cultured biomass.
Detailed data on the amounts of SL obtained on the tested
MS media variants after each duration of the growth period is
included in supplementary materials as Tables S1–S6 (Online
resource). Based on the analyses, considerable differences in
the amounts of individual compounds and in their total con-
tent were found depending on the combination of the PGRs
used in the culture medium. The amounts of the individual SL
varied within very wide limits, e.g. for schisandrin from 25.6
to 176.3 mg/100 g DW, for schisantherin B from 7.2 to
50.1 mg/100 g DW and for the total content from 125.3 to
490.3 mg/100 g DW (Table 4). Higher SL content was
obtained in extracts from the biomass grown on variants
B–G than in extracts of the biomass grown on variant A
(Tables S1–S6). The quantitatively dominant lignans in
extracts from the agar cultures were as follows:
schisandrin (max. 176.3 mg/100 g DW, variant E, cul-
ture duration—30 days), angeloylgomisin Q (max.
85.1 mg/100 g DW, variant E, culture duration—
50 days), schisantherin B (max. 50.1 mg/100 g DW,
variant E, culture duration—10 days), gomisin A (max
49.6 mg/100 g DW, variant G, culture duration—
30 days) and deoxyschisandrin (max. 34.1 mg/100 g
DW, variant G, culture duration—30 days) (Table 4).
The maximum total SL content (574.4 mg/100 g DW) was
found after 10 days of growth on variant E of the culture
medium. However, the biomass growth during this period
was low (Gi = 2.3). High production of SL (490.3 mg/100 g
DW) was also found on the same MS medium variant in
extracts from the microshoots harvested after 30 days, for
which the Gi factor was higher (Gi = 4.8) (Tables 4 and S3).
After that period, the observed increase in SL in the
microshoot cultures was the highest (Fig. 5). High total
amounts of lignans were also obtained in the microshoots after
30 days of their cultivation on variants E and F of MS medi-
um. The lowest total SL content was found after 20 days of
culture on variant C. Greater amounts of lignans were obtain-
ed in biomasses grown on the test variants D, E, F and G than
on the control medium, variant A (containing no PGRs). The
results on variants B and C were comparable with the control
(Table 4, Fig. 5).
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Agitated microshoot cultures
The appearance of the biomass in the agitated shoot cultures
depended on the variant of MS medium and the duration of
the culture cycle. The largest increases in biomass were found
after 60 days of culture on variant F, and the smallest after
10 days of culture on variant G (Fig. 2). Depending on the
medium variant and culture duration, the obtained increases in
dry biomass, expressed by the growth index (Gi), ranged from
1.4 to 7.5 times. The highest increases were obtained for cul-
tures cultivated for 60 days on variant H (Table 3).
Based on the HPLC-DAD analyses, considerable differ-
ences were found in the amounts of the individual compounds
as well as in their total amount, depending on the combination
of PGRs used in the culture medium. The amounts of the
individual SL varied within very wide limits, e.g. for
schisandrin from 26.8 to 112.3 mg/100 g DW, for
schisantherin B from 9.6 to 29.9 mg/100 g DW and for the
total content from 112.0 to 414.8 mg/100 g DW (Table 5).
The quantitatively dominant SL in extracts from the bio-
mass of the agitated cultures were as follows: schisandrin
(max. 112.3 mg/100 g DW, variant G, culture duration—
30 days), gomisin A (max. 71.4 mg/100 g DW, variant G,
culture duration—30 days), angeloylgomisin H (max.
44.8 mg/100 g DW, variant G, culture duration—30 days),
angeloylgomisin Q (max. 31.2 mg/100 g DW, variant F, cul-
ture duration—30 days), schisantherin B (max. 29.9 mg/100 g
DW, var iant G, cul ture dura t ion—30 days) and
deoxyschisandrin (max. 27.3mg/100 g DW, variant G, culture
duration—20 days) (Tables S7–S12, and Table 5). Extracts
from the culture media were found to contain only trace
amounts of SL (less than 0.1 mg/l).
The maximum total SL content in extracts from agitated
microshoot cultures was obtained after 30 days of cultivation
on variant G (Table 5 and Fig. 6). The lowest total SL content
was found after 60 days of cultivation on variant F medium.
The 30-day growth period and application of variant G of MS
medium yielded the most satisfactory results in terms of cul-
ture growth and SL accumulation (Fig. 6).
Bioreactor cultures
The best conditions determined on the basis of the results of
SL accumulation obtained during the testing of agitated cul-
tures were chosen for the bioreactor-grown microshoot cul-
tures of SchS. Themost favorable mediumwas theMS variant
G and a 30-day growth period. Based on the observations of
microshoot morphology, vital growth of tissue under cultiva-
tion in the temporary immersion system was found (Fig. 3).
The growth increments, expressed as Gi, were high, equal to
4.6 (Table 6).
The dominant compounds in extracts from the microshoots
not subjected to elicitation were as follows: schisandrin
(115.3 mg/100 g DW), schisantherin B (35.6 mg/100 g DW)
Table 2 Schisandra lignans
contents (mg/100 g DW±SD) in
fruit and leaves extracts of
S. chinensis cv. Sadova and
S. chinensis
Lignans S. chinensis cv. Sadova S. chinensis*
Fruits Leaves Fruits Leaves
Schisandrin 166.8 ± 11.0bcd 55.1 ± 3.6acd 132.4 ± 9.4abd 29.7 ± 1.4abc
Gomisin A 72.4 ± 12.2bcd 12.5 ± 3.7acd 109.4 ± 8.3abd 34.5 ± 2.2abc
Angeloyl-/tigloylgomisin H 71.6 ± 8.3bcd 31.4 ± 1.5acd 161.9 ± 10.1abd 51.2 ± 5.8abc
Angeloyl-/tigloylgomisin Q 24.5 ± 6.3bcd 13.4 ± 0.4acd 52.3 ± 4.9abd 8.2 ± 1.1abc
Gomisin G 4.8 ± 0.4bcd 1.9 ± 0.3acd 46.1 ± 3.1ab 49.1 ± 2.9ab
Schisantherin A 19.5 ± 2.3bcd 3.5 ± 0.2acd 25.5 ± 2.5ab 25.9 ± 3.1ab
Schisantherin B 56.8 ± 8.2bcd 4.6 ± 0.5acd 4.7 ± 1.0ad 3.4 ± 0.3abc
Schisanthenol 2.6 ± 0.2bcd 1.4 ± 0.2acd 3.6 ± 0.4abd 2.7 ± 0.5bc
Deoxyschisandrin 31.2 ± 2.5bcd 16.1 ± 2.7acd 60.7 ± 5.2abd 41.1 ± 3.8abc
Schisandrin B 58.9 ± 3.5bd 11.9 ± 2.1acd 56.8 ± 3.1bc 21.8 ± 1.3abc
γ-Schisandrin 96.2 ± 4.0bcd 24.5 ± 1.7ac 66.5 ± 2.5abd 22.3 ± 2.0ac
Benzoylgomisin P 12.4 ± 1.9bd 23.0 ± 2.8acd 13.4 ± 0.4ab 14.4 ± 1.1ab
Schisandrin C 7.0 ± 0.2bd 10.1 ± 0.3ac 6.1 ± 1.1abd 10.9 ± 1.3ac
Schisantherin D 21.3 ± 2.3bcd 31.3 ± 2.3acd 15.2 ± 0.9abd 7.8 ± 0.4abc
Total content 646.0 ± 63.3bcd 240.7 ± 22.3acd 754.6 ± 52.8abd 322.8 ± 27.1abc
*According to Szopa et al. 2016b
a p < 0.05 vs. S. chinensis cv. Sadova Fruits
b p < 0.05 vs. S. chinensis cv. Sadova Leaves
c p < 0.05 vs. S. chinensis Fruits
d p < 0.05 vs. S. chinensis Leaves
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and angeloylgomisin H (30.1 mg/100 g DW) (Table 6). The
total SL content was 313.5 mg/100 g DW.
The experiment with Plantform bioreactor-grown
microshoots was expanded to include elicitor treatments using
1 g/l YE on day 20 of biomass growth. In extracts from the
elicited microshoots, the amounts of the individual compounds
increased from 1.22- to 1.53-fold (Table 6). The dominant com-
pounds were as follows: schisandrin (144.3 mg/100 g DW),
schisandrin B (44.2 mg/100 g DW), gomisin A (42.6 mg/
100 g DW) and angeloylgomisin H (45.1 mg/100 g DW).
The total content was 408.3 mg/100 g DW, which was 1.30
times higher than in extracts from themicroshoots not subjected
to elicitation (Table 6). The Plantform culture media were found
to contain only trace amounts of SL (less than 0.1 mg/l).
Discussion
The results of chromatographic analyses of SL in extracts
from fruits and leaves of SchS showed that the qualitative
composition of lignan fraction was the same as in the Sch
plant matrices analysed by Szopa et al. (Szopa et al.
2016b). However, the two plants differed with respect to
the amounts of individual compounds. Importantly, higher
concentrations of the analysed SL were found in the
schisandra cultivar. The amounts of SL in the extracts
from fruits and leaves of SchS were 1.17- and 1.34-fold
higher, respectively, than in the extracts from the basic
species (Sch) which is widely distributed and utilized as
a medicinal plant (Table 2).
The same lignans were dominant in extracts from the fruits
of both plants , namely schisandr in , gomisin A,
angeloylgomisin H and γ-schisandrin. However, the
schisandrin and γ-schisandrin contents in SchS fruit extracts
were respectively 1.26- and 1.45-fold higher, and those of
gomisin A and angeloylgomisin H respectively 1.51- and
2.26-fold lower than in Sch fruit extracts. The schisantherin
B content in SchS fruit extracts was 12-fold higher.
In extracts from the leaves of Sch and SchS, differ-
ent lignans were shown to prevail. SchS leaf extracts
were found to contain greater amounts of some of SL:
1.86 times more schisandrin and 4.02 times more
schisantherin D (Table 2).
In the light of the presented comparative phytochemical stud-
ies, SchS proved to contain higher amounts of SL than the
parent species (Sch). Given the fact that these compounds large-
ly determine the therapeutic properties of Schisandra species,
SchS can be proposed as a new raw material for pharmaceutical
use. However, broader phytochemical studies are required to
evaluate SchS for the presence of other biologically active
Table 3 Changes in growth index–Gi (calculated according to the
formula: Gi = [(Dw1 −Dw0)/Dw0] where Dw1 is the dry weight of
microshoots at the end of experiment and Dw0 is the dry weight of the
inoculum), of S. chinensis cv. Sadova biomass from all tested in vitro
systems (agar, agitated and Plantform bioreactor-grown cultures).
Values represent the mean ± SD of four samples
Type of S. chinensis cv.
Sadova microshoot cultures
MS medium variant* Culture growth period
10 days 20 days 30 days 40 days 50 days 60 days
Agar A 2.7 ± 0.1cdef 2.9 ± 0.2cdef 3.5 ± 0.1abef 3.5 ± 0.4abef 3.8 ± 0.3abcdf 3.9 ± 0.6abcde
B 2.5 ± 0.1bcdef 3.8 ± 0.3acdef 4.4 ± 0.2abdef 4.0 ± 0.6abcef 5.2 ± 0.5abcdf 5.7 ± 0.3abcde
C 2.5 ± 0.3bcdef 4.1 ± 0.2acdef 3.7 ± 0.5abef 3.7 ± 0.2abef 7.2 ± 0.2abcdf 5.7 ± 0.3abcde
D 2.5 ± 0.1bcdef 3.5 ± 0.5adef 3.5 ± 0.2adef 4.1 ± 0.5abcef 4.9 ± 0.1abcdf 6.3 ± 0.8abcde
E 2.3 ± 0.2bcdef 2.8 ± 0.2acdef 3.1 ± 0.3abdef 5.0 ± 0.6abced 6.1 ± 0.1abcdf 5.8 ± 0.3abcde
F 2.5 ± 0.1bcdef 3.2 ± 0.6acdef 3.6 ± 0.3abdef 5.6 ± 0.8abcef 5.3 ± 0.2abcdf 6.8 ± 0.7abcde
G 2.8 ± 0.1bcdef 3.4 ± 0.5acdef 4.8 ± 0.6abdef 6.8 ± 0.2abcef 7.1 ± 0.1abcdf 8.7 ± 0.6abcde
Agitated F 1.9 ± 0.1bcdef 2.3 ± 0.2acdf 2.9 ± 0.4abdef 3.4 ± 0.5abcef 2.3 ± 0.1acdf 7.5 ± 0.4abcde
G 1.4 ± 0.1bcdef 2.5 ± 0.2acef 2.2 ± 0.6abdef 2.6 ± 0.09abcef 4.4 ± 0.2abcdf 4.1 ± 0.2abcde
Plantform G nt nt 4.6 ± 0.9
4.7 ± 0.1**
nt nt nt
nt not tested
*See ‘Materials and methods’; **Gi of microshoots after elicitor (YE) treatment
a p < 0.05 vs. 10-day growth period
b p < 0.05 vs. 20-day growth period
c p < 0.05 vs. 30-day growth period
d p < 0.05 vs. 40-day growth period
e p < 0.05 vs. 50-day growth period
f p < 0.05 vs. 60-day growth period
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metabolites like phenolics and polysaccharides. The results en-
courage further phytochemical studies on SchS.
Literature data confirm the fact that cultivated varieties of
medicinal plant species are often more useful as a source of
raw materials for pharmaceutical, cosmetic and dietary use.
Cultivars are often characterized as being easier to grow, more
resistant to external factors and more productive like Aronia
melanocarpa cv. Galicjanka (Wangensteen et al. 2014),
Cannabis sativa cv. Uso 11 (Sankari 2000), Vitis vinifera
cvs. Palatina and Swenson Red (Elmer) (Corrales et al.
2008), or Zea mays cvs. Rugosa and Pioneer (Drew and
Läuchli 1985). Many vegetable cultivars are characterized
by high production of active ingredients—such as Anethum
graveolens (26 various cvs.) with a high essential oil content
(Bailer et al. 2001), Ipomoea batatas cvs. Lunyangwa,
Semusa, Kenya, Zondeni and Mugamba with a high starch
content (Tsakama et al. 2010), Daucus carota cvs. Kazan
and Kamaran with a high carotenoid content (Czepa and
Hofmann 2004). Levels of biologically active compounds
have been studied in cultivars of other medicinal plants; anal-
yses have demonstrated, for example, a high phenolic content
and high radical scavenging potential of Arnica montana cv.
Arbo (Spitaler et al. 2008) and Matricaria chamomilla cv.
Bona (Ganzera et al. 2008), or high levels of isoflavones in
Table 4 The comparison of
schisandra lignans yielding in
S. chinensis cv. Sadova agar
microshoot cultures—changes in
dependence on applied duration
of growth period and media
variants. Results correspond to
Tables 2 and S1–S6
Lignans Content (mg/
100 g DW)
min.–max.
Increase
(fold)
Optimal growth
period (days)
Optimal
medium
variant*
Gi for optimal
conditions
Schisandrin 25.6–176.3 6.9 30 E 3.1
Gomisin A 8.7–49.6 5.7 30 G 4.8
Angeloyl-/tigloylgomisin
H
13.5–67.0 5.0 10 E 2.3
Angeloyl-/tigloylgomisin
Q
10.8–85.1 7.9 50 E 6.1
Gomisin G 3.7–20.5 5.5 50 G 7.1
Schisantherin A 1.2–13.7 11.7 10 E 2.3
Schisantherin B 7.2–50.1 6.9 10 E 2.3
Schisanthenol 0.2–3.2 14.0 50 G 7.1
Deoxyschisandrin 12.0–34.1 2.9 30 G 4.8
Schisandrin B 3.1–27.4 8.7 40 G 6.8
γ-Schisandrin 1.6–22.8 14.7 60 D 6.3
Benzoylgomisin P 4.4–39.8 9.0 50 G 7.1
Schisandrin C 1.9–18.4 9.5 60 G 8.7
Schisantherin D 2.9–58.7 20.0 10 E 2.3
Total content 125.3–490.3 4.6 30 E 4.8
*See ‘Materials and methods’
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Glycine max cv. Saeolkong (Lee et al. 2009). Our results for
the cultivar of Chinese magnolia vine correspond with those
findings.
Besides examining SchS raw materials for SL content, the
current study involved establishing in vitro shoot cultures of
the Sadova cultivar, with the aim of providing an alternative,
sustainable source of the aforementioned compounds. So far,
there have been only few reports on in vitro cultures of Sch,
including the projects of the authors of this paper (Březinová
et al. 2010; Kohda et al. 2012; Szopa and Ekiert 2012; Szopa
et al. 2016b), whereas in vitro cultures of SchS has not been
studied at all.
In general, microshoot cultures of SchS were shown to
accumulate higher amounts of SL as compared with previous
reports. For instance, Brezinová et al. (Březinová et al. 2010)
estimated the following amounts of SL in embryogenic Sch
cultures cultivated on aWestvaco agar medium (with 0.9 mg/l
BA and 2.21mg/l 2,4-D (2,4-dichlorophenoxyacetic acid)): γ-
schisandrin (max. 13.9 mg/100 g DW), gomisin A (max.
11.9 mg/100 g DW), deoxyschisandrin (max. 9.6 mg/100 g
DW), schisandrin C (max. 7.3 mg/100 g DW) and schisandrin
(max. 0.9 mg/100 g DW). In comparison with these results,
the amounts of SL obtained in our SchS agar microshoot cul-
tures were respectively 1.64-, 4.16-, 3.54-, 2.51- and 195.90-
fold higher (Table 3).
In a study conducted by Kohda et al. (Kohda et al. 2012),
Sch callus cultures were grown on ½ MS medium enriched
with kinetin (0.05 mg/l) and 2,4-D (0.2 mg/l). Only two of the
six analysed lignans, namely gomisin A (max 0.05 mg/100 g
DW) and gomisin F (max 0.04 mg/100 g DW), were found in
Table 5 The comparison of
schisandra lignans yielding in
S. chinensis cv. Sadova agitated
microshoot cultures—changes in
dependence on applied duration
of growth period and media
variants. Results correspond to
Tables 2 and S7–S12
Lignans Content (mg/
100 g DW)
min.–max.
Increase
(fold)
Optimal growth
period (days)
Optimal
medium
variant*
Gi for optimal
conditions
Schisandrin 26.8–112.3 4.2 30 G 2.2
Gomisin A 17.6–71.4 4.1 30 G 2.2
Angeloyl-/tigloylgomisin
H
11.9–44.8 3.8 30 G 2.2
Angeloyl-/tigloylgomisin
Q
4.0–31.2 7.9 30 F 2.9
Gomisin G 1.3–9.5 7.2 20 G 2.5
Schisantherin A 1.4–7.5 5.2 30 G 2.2
Schisantherin B 9.6–29.9 3.1 30 G 2.2
Schisanthenol 0.7–8.4 11.6 30 G 2.2
Deoxyschisandrin 12.4–27.3 2.2 20 G 2.5
Schisandrin B 0.1–11.5 114.9 30 F 2.9
γ-Schisandrin 1.3–10.5 8.0 20 G 2.5
Benzoylgomisin P 2.4–22.0 9.2 30 F 2.9
Schisandrin C 0.5–6.1 11.4 20 F 2.3
Schisantherin D 2.4–22.3 9.2 30 G 2.2
Total content 120.0–414.8 3.5 30 G 2.2
*See ‘Materials and methods’
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the biomass. The amount of gomisin A obtained in extracts
from our SchS agar microshoot cultures was 99.10 times
higher (Table 4).
Comparing the results of this study on SchS with our pre-
vious work on Sch agar cultures (Szopa et al. 2016b), it was
found that the qualitative composition of SLwas the same, but
the amounts of specific constituents were different. In SchS
agar cultures, the amounts of the main SL, schisandrin,
deoxyschisandrin and gomisin A, were respectively 3.15-,
1.12-, 1.91-fold greater than the amounts of these compounds
obtained in Sch microshoots on the corresponding variants of
the culture medium. Also, the present study found SchS
microshoots to contain 62.61-, 32.71- and 14.26-fold greater
amounts of schisantherin B, schisantherin A and gomisin G,
respectively, in comparison with Sch. Moreover, in SchS cul-
tures, the amounts of angeloylgomisin Q and angeloylgomisin
H were respectively 1.66- and 2.51-fold greater than the
amounts in Sch biomass. The maximum total SL content ob-
tained in extracts from the biomass from SchS agar cultures
was 2.41 times higher than in extracts from Sch agar cultures
(Table 7).
In the study by Brezinová et al. (Březinová et al. 2010)
conducted on Sch suspension cultures, the dominant com-
pounds were gomisin N (max. 54.7 mg/100 g DW), γ-
schisandrin (max. 55.0 mg/100 g DW) and schisandrin C
(max. 20.9 mg/100 g DW) whereas deoxyschisandrin
(4.9 mg/100 g DW), gomisin A (max. 4.4 mg/100 g DW)
and schisandrin (max. 1.0 mg/100 g DW) accumulated in
smaller amounts. The maximum concentrations of γ-
schisandrin and schisandrin C in extracts from the biomass
of SchS agitated cultures were respectively 5.23 and 3.41
times smaller, and those of deoxyschisandrin 5.57 times great-
er than in extracts from the biomass of Sch suspension cul-
tures. The current study also found 112.31- and 16.23-fold
higher levels of schisandrin and gomisin A, respectively
(Table 7).
The comparison of our studies on agitated microshoot cul-
tures of SchS and Sch demonstrated that both plants have the
same qualitative composition of SL; however, differences
were shown in the amounts of the specific lignans. The dom-
inant compounds in Sch agitated cultures were schisandrin,
deoxyschisandrin and gomisin A. The maximum amounts of
schisandrin and gomisin A were respectively 2.66 and 2.58
times lower, and those of deoxyschisandrin 1.31 times higher
than the amounts of these compounds obtained in SchS agi-
tated cultures. The amounts of schisanthenol, schisantherin B
and gomisin G obtained in extracts from SchS agitated cul-
tures were respectively 6.53-, 5.24- and 4.98-fold higher com-
pared with agitated cultures of S. chinensis. The amounts of
angeloylgomisin Q and angeloylgomisin H in Sch agitated
microshoot cultures were 1.42 times higher and 1.70 times
lower, respectively, in comparison with SchS. Also, the
amounts of schisantherin D and schisandrin B obtained with
SchS were 4.27 and 2.02 times greater, respectively, than in
Sch agitated cultures. The maximum total SL content obtained
in extracts from the biomass from SchS agitated cultures was
1.69 times higher than in extracts from Sch agitated cultures
(Table 7).
The bioreactor-grown SchS microshoots, in comparison
with Sch microshoots cultivated under the same conditions
(Szopa et al. 2017b), were found to contain greater amounts
of three main SL: schisantherin B (3.62 times), schisandrin C
Table 6 Schisandra lignans
contents (mg/100 g DW±SD) in
extracts from microshoots
S. chinensis cv. Sadova cultivated
in Plantform temporary
immersion system on MS variant
G for 30-day growth periods (n =
3). I—microshoots without elici-
tation; II—microshoots elicitated
with 1 g/l of YE (yeast extract) on
the 20th day of growth period
Lignans I II Increase (fold)
Schisandrin 115.3 ± 1.4b 144.4 ± 2.8a 1.3
Gomisin A 27.9 ± 1.3b 42.6 ± 0.7a 1.5
Angeloyl-/tigloylgomisin H 30.0 ± 0.7b 45.1 ± 9.6a 1.5
Angeloyl-/tigloylgomisin Q 18.3 ± 0.2b 22.3 ± 0.7a 1.2
Gomisin G 9.5 ± 0.2b 12.0 ± 1.6a 1.3
Schisantherin A 4.1 ± 0.1b 5.0 ± 0.2a 1.2
Schisantherin B 35.6 ± 0.5b 44.2 ± 4.6a 1.2
Schisanthenol 1.1 ± 0.2 1.4 ± 0.5 1.4
Deoxyschisandrin 9.6 ± 0.2b 13.2 ± 1.1a 1.4
Schisandrin B 9.1 ± 0.2b 11.0 ± 0.4a 1.2
γ-Schisandrin 2.3 ± 0.1b 2.8 ± 0.1a 1.3
Benzoylgomisin P 12.3 ± 0.2b 15.4 ± 0.5a 1.3
Schisandrin C 16.6 ± 0.4b 20.8 ± 0.6a 1.3
Schisantherin D 22.0 ± 0.3b 28.2 ± 0.5a 1.3
Total content 313.5 ± 6.1b 408.3 ± 23.9a 1.3
a p < 0.05 vs. I—microshoots without elicitation
b p < 0.05 vs. II—microshoots elicitated with 1 g/l of YE (yeast extract) on the 20th day of growth period
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(3.32 times) and schisantherin D (2.70 times) (Table 7).
However, the total SL content in Plantform-grown SchS was
1.74 times lower than in Sch.
The elicitation experiment performed on Plantform-grown
microshoots of SchS increased the total amount of SL 1.30
times; however, the obtained amounts were still lower than in
non-elicited Sch microshoots grown in the same temporary-
immersion system (Szopa et al. 2018). The applied elicitation
scheme, taken directly from our previous report, may not be
optimal for in vitro shoots of Schisandra cultivar. Further
optimization of the experiment is required to determine the
type, concentration and application time of the elicitor, as well
as the cultivation mode providing highest SL yield. Indeed,
our previous trials on Sch in vitro cultures had indicated that
the amounts of SL in the microshoots vary considerably de-
pending on bioreactor type (Szopa et al. 2017b) and elicitation
scheme (Szopa et al. 2018). Moreover, as it has been demon-
strated with other in vitro cultures of medicinal plant species,
like Panax ginseng (Thanh et al. 2005), Taxus chinensis
(Dong and Zhong 2002) and Withania somnifera
(Sivanandhan et al. 2014), these conditions must be designed
for each types of in vitro cultures and plant species
individually.
As a result of the experiments with SchS, a cultivar of Sch,
quantitative differences in the chemical composition in vitro
cultures of different cultivars were proven. Similar correla-
tions of the diversity in the characteristics of cultivated varie-
ties have been confirmed by studies conducted on other cul-
tures in vitro. These differences are most often presented in
reports on micropropagation. The necessity of introducing
different schemes for dealing with cultivars of the same spe-
cies have been demonstrated for Hibiscus cannabinus cv.
Guangdong 743-2 (Ayadi et al. 2011), Pyrus communis cv.
Cascatense (De Castro Da Silva et al. 2016) and Vitis vinifera
cv. Cabernet Sauvignon (Laslo et al. 2010). Particularly note-
worthy are studies on the accumulation of biologically active
metabolites in the biomass of in vitro cultures of cultivated
varieties such as in vitro cultures of three cultivars of
Hypericum perforatum—Elixir, Helos and Topas (Kwiecień
et al. 2015; Kwiecień et al. 2018). The richest source of the
estimated compounds, i.e. phenolic acids and flavonoids, and
hence a potential biotechnological platform, were the shoots
of cv. Helos cultivated in an agitated culture system on LS and
MS media containing low concentrations of BA and NAA
(0.1–1.0 mg/l). Variability in the accumulation of free proline
has been observed in different cultivars of Phaseolus vulgaris
Table 7 Comparison of schisandra lignans contents (mg/100 g DW±SD) in agar, agitated and Plantform bioreactormicroshoots cultures of S. chinensis
cv. Sadova and S. chinensis on MS medium variant G, for 30 days
Lignans S. chinensis cv. Sadova S. chinensis*
Agar Agitated Bioreactor Agar Agitated Bioreactor
Schisandrin 99.0 ± 7.1bcdef 112.3 ± 6.8ade 115.3 ± 1.4ade 53.0 ± 0.2abcef 38.0 ± 2.4abcdf 118.6 ± 1.5abde
Gomisin A 49.6 ± 1.6bcdef 71.4 ± 6.9acde 27.9 ± 1.3abdf 25.9 ± 2.0abf 24.4 ± 0.2abcf 67.9 ± 2.6abcde
Angeloyl-/tigloylgomisin H 54.3 ± 12.3bcde 44.8 ± 1.9acdef 30.0 ± 0.7abef 26.7 ± 1.2abcf 22.0 ± 0.3abcf 53.5 ± 2.4bcde
Angeloyl-/tigloylgomisin Q 67.7 ± 2.6bcdef 30.6 ± 0.8acdef 18.3 ± 0.2abdef 51.2 ± 2.6abcef 34.6 ± 0.4acdf 100.1 ± 3.1abcde
Gomisin G 10.7 ± 0.2bcdef 6.5 ± 4.3acdef 9.5 ± 0.2bdef 1.4 ± 0.8abcf 1.4 ± 0.1abcf 2.7 ± 0.5abcde
Schisantherin A 8.0 ± 0.3bcdef 7.5 ± 0.2cdef 4.1 ± 0.1abdef 0.4 ± 0.2abcef 3.1 ± 0.1abcde 3.0 ± 0.1abcd
Schisantherin B 33.8 ± 1.0bdef 29.9 ± 1.4acdef 35.6 ± 0.5bdef 0.8 ± 0.1abcef 3.4 ± 0.1abcdf 9.9 ± 2.1abcde
Schisanthenol 2.2 ± 0.1bcdef 8.4 ± 1.9acdeg 1.1 ± 0.2abd 0.5 ± 0.1abcf 1.0 ± 0.1abd 1.3 ± 0.3abd
Deoxyschisandrin 34.0 ± 0.8bcdef 21.5 ± 0.5acdef 9.6 ± 0.2abdef 30.3 ± 1.9bcf 27.6 ± 0.3abcf 77.7 ± 4.9abcde
Schisandrin B 22.4 ± 0.5bcdef 0.4 ± 0.2acdef 9.1 ± 0.2abdef 14.5 ± 1.4abcef 13.6 ± 0.2abcdf 39.7 ± 3.4abcde
γ-Schisandrin 16.8 ± 0.9bcdef 5.7 ± 0.8acdef 2.3 ± 0.1abdef 8.1 ± 0.3abcef 7.6 ± 0.2abcf 22.4 ± 0.2abcdef
Benzoylgomisin P 27.0 ± 2.5bcdef 9.0 ± 0.3acdef 12.3 ± 0.2abdef 17.5 ± 0.9abcef 13.7 ± 0.1abdf 37.2 ± 0.9abcde
Schisandrin C 12.4 ± 0.5bcdef 4.9 ± 0.2acdef 16.6 ± 0.4abdef 2.4 ± 0.5abcf 2.0 ± 0.1abcf 5.1 ± 0.8acde
Schisantherin D 52.4 ± 1.2bcdef 22.3 ± 0.5adef 22.0 ± 0.3adef 5.3 ± 0.9abcef 3.0 ± 0.2abcdf 8.2 ± 0.8abcde
Total content 490.3 ± 31.5bcdef 375.1 ± 26.6acdef 313.5 ± 6.1abdef 237.9 ± 4.5abcef 195.2 ± 9.5abcdf 547.0 ± 12.5abcde
*According to Szopa et al. 2017b
a p < 0.05 vs. S. chinensis cv. Sadova agar in vitro cultures
b p < 0.05 vs. S. chinensis cv. Sadova agitated in vitro cultures
c p < 0.05 vs. S. chinensis cv. Sadova bioreactor in vitro cultures
d p < 0.05 vs. S. chinensis agar in vitro cultures
e p < 0.05 vs. S. chinensis agitated in vitro cultures
f p < 0.05 vs. S. chinensis bioreactor in vitro cultures
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cvs. Pinto Americano, Pastilla, Flor de Mayo and Flor de
Junio (Cárdenas-Avila et al. 2006). The most promising re-
sults were confirmed for cv. Pinto Americano.
In recent decades, in vitro cultures of several medicinal
plants were investigated as an alternative for traditional crops
or wild-grown species. This type of studies are boosted by
limited natural resources of medicinal plants which are not
sufficient to meet the growing market demands. Examples of
successful research in this field include in vitro cultures of
Catharanthus roseus (Vázquez-Flota et al. 2009), Panax
ginseng (Thanh et al. 2005) or Salvia miltiorrhiza (Zhao
et al. 2010), which were employed for the production of bio-
mass and/or bioactive compounds of interest. In the presented
work, in vitro cultures of SchS were evaluated for their utility
as a sustainable source of SL. The maximal total amounts of
SL obtained through testing different culture conditions
(490.3 mg/100 g DW) was 2.04 times higher than in leaf
extract and only 1.32 times lower than in the fruit extract od
parent plant (Tables 2 and 7). Also the individual contents of
some SL were higher in the microshoot extracts than in
analysed for comparative purpose fruit and leaf extracts of
soil-grown plant. The amounts of the main SL with high ther-
apeutic value were respectively 1.45 and 2.09 (schisandrin)
and 2.23 and 5.63 (gomisin B) times higher in extracts from
in vitro cultures. Since the above compounds are considered to
be responsible for biological activity of Schisandra extracts
(Szopa et al. 2017a), the obtained cultures may serve as a
material for their isolation. In the course of the study, we have
also optimized the growth conditions of SchS microshoots in
the temporary immersion system (Plantform bioreactors)
which enable effective propagation of microshoots with rela-
tively low cost (Szopa et al. 2017b). These experiments in-
cluded the stimulation of SL biosynthesis by elicitation, thus
providing an opportunity for the scale up the production of
SL-enriched biomass (Table 6). Promising results encourage
further experiments in the field. Most importantly, our find-
ings demonstrated that SchS is a rich source of SL, thus prov-
ing its value for medical, cosmetic and food industry.
The chromatographic analyses of all analysed SL
standards (nine compounds) performed under our study
was confirmed by validation procedure compatible with
European Medicines Agency standards based on accura-
cy, precision, linearity, limit of detection and limit of
quantification (European Medicines Agency 2005) (see
section ‘Validation setup’).
Within the framework of our phytochemical and what is the
most important, biotechnological studies of a cultivar of Sch,
our results indicated, for the first time, the highest utility of
SchS with regard to higher concentrations of SL. These com-
pounds are responsible for a wide range of biological proper-
ties, especially of fruits, which determine their application in
medicine, phytotherapy and cosmetology industry (Walsh
2003; Schneider et al. 2013).
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